Research ArticleClinical Investigation

Clinical Outcomes of 177Lu-DOTATATE Peptide Receptor Radionuclide Therapy in Patients with Skeletal Metastases from Neuroendocrine Tumors: Insights from Real-World Experience

Kunal Ramesh Chandekar, Swayamjeet Satapathy, Sanjana Ballal, Madhav Prasad Yadav, Shubha Gadde Ravindra, Sameer Rastogi, Ranjit Kumar Sahoo and Chandrasekhar Bal
Journal of Nuclear Medicine May 2025, jnumed.125.269456; DOI: https://doi.org/10.2967/jnumed.125.269456

Article Information

jnumed.125.269456
DOI 
https://doi.org/10.2967/jnumed.125.269456
PubMed 
40404399
Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication January 3, 2025
  • Accepted for publication April 29, 2025
  • Published online May 22, 2025.
Copyright & Usage 
© 2025 by the Society of Nuclear Medicine and Molecular Imaging.

Author Information

  1. Kunal Ramesh Chandekar1,
  2. Swayamjeet Satapathy1,
  3. Sanjana Ballal1,
  4. Madhav Prasad Yadav1,
  5. Shubha Gadde Ravindra1,
  6. Sameer Rastogi2,
  7. Ranjit Kumar Sahoo2 and
  8. Chandrasekhar Bal1
  1. 1Department of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi, India; and
  2. 2Department of Medical Oncology, All India Institute of Medical Sciences, New Delhi, India
  1. For correspondence or reprints, contact Chandrasekhar Bal (csbal{at}hotmail.com).
View Full Text

Statistics from Altmetric.com

Cited By...

Article usage

Article usage:

No statistics are available.
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools
Bookmark this article

Jump to section

Keywords